1 Comment
User's avatar
⭠ Return to thread
Winton Gibbons's avatar

You rhetorically asked: “Why was this study done? Why was it published?” These questions could be asked of virtually all biomarker studies. Those studies almost never look at clinical utility (are the important outcomes, like mortality, better; does it even change treatment?) They are often even underpowered or not for the intended use populations. They typically are of the “gosh, look these things seem (weakly) correlated with those things” kind of science.

Expand full comment